EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fetuin-A: a potential molecular link between obesity, diabetes (type 2 and type 1) and metabolic steatotic liver disease (MASLD)

Ilaria Milani, Gabriele Ciasca, Marianna Chinucci, Valeria Carnazzo, Frida Leonetti, Umberto Basile, Danila Capoccia

Journal of Endocrinological Investigation · 04.05.2026 · 49 (8) · 2033-2043

DOI: 10.1007/s40618-026-02880-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinological Investigation, online erschienen am 04.05.2026. Verfasst von Ilaria Milani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medico-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, University of Rome La Sapienza, Latina, Lazio, 04100, I…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Obesity, alpha-2-HS-Glycoprotein, Biomarkers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Roma La Sapienza.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Fetuin-A represents a novel molecular target involved in the complex pathogenesis of metabolic disorders. This study aimed to evaluate its association with obesity, type 2 (T2DM) and type 1 (T1DM) diabetes and its correlation with non-invasive liver assessment.

Methods

105 patients (38 with obesity without T2DM, 30 with T2DM, and 37 with T1DM) and 13 controls were included. All participants underwent transient elastography (TE) with controlled attenuation parameter (CAP), and liver stiffness measurement (LSM), clinical and biochemical data (including fetuin-A).

Results

Fetuin-A was significantly higher in all clinical groups than controls, with the greatest increase observed in obesity without T2DM. Fetuin-A correlated positively with measures of adiposity (BMI, waist circumference, waist to height ratio), triglycerides, and non-invasive indicators of liver steatosis (Fatty Liver Index and CAP), while showing no association with fibrosis (defined by LSM ≥ 7.9 kPa). In age- and sex-adjusted models, fetuin-A remained independently associated with obesity and T1DM, whereas T2DM showed a negative but not significant association. Fetuin-A was significantly higher in steatosis, with good discriminatory ability (AUC 0.84, 95% CI 0.77–0.91) and a sensitivity of 0.75 and specificity of 0.74 at the optimal Youden threshold. Negative association with male sex and positive association with age was also observed.

Conclusions

Results confirm fetuin-A as a molecular signature of metabolic disorders, mediating the cross-talk between liver and adipose tissue. Further studies are needed to validate it as a useful biomarker for the early diagnosis and monitoring of liver and metabolic disease, including obesity, T2DM, T1DM, and MASLD, and to reach a consensus on reference values definition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Obesityalpha-2-HS-GlycoproteinBiomarkersDiabetes Mellitus, Type 1Non-alcoholic Fatty Liver DiseaseFatty LiverHumansMaleFemaleMiddle AgedAdultCase-Control StudiesPrognosis

Stichwörter der Autor:innen

Fetuin-AFibrosisMASLDNon-invasive assessmentObesityType 1 diabetesType 2 diabetes

Substanzen

alpha-2-HS-GlycoproteinBiomarkersAHSG protein, human

Autor:innen und Institutionen

  • Department of Medico-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, University of Rome La Sapienza, Latina, Lazio, 04100, Italy. ilaria.milani@uniroma1.it.
  • Department of Neuroscience, Physics Section, Catholic University of Sacred Heart, Rome, Lazio, 00168, Italy.
  • Department of Medico-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, University of Rome La Sapienza, Latina, Lazio, 04100, Italy.
  • Department of Clinical Pathology, Ospedale Santa Maria Goretti, Latina, Lazio, 04100, Italy.

Förderung

  • Università degli Studi di Roma La Sapienza

Zitieren

APA

Milani, I., Ciasca, G., Chinucci, M., Carnazzo, V., Leonetti, F., Basile, U., & Capoccia, D. (2026). Fetuin-A: a potential molecular link between obesity, diabetes (type 2 and type 1) and metabolic steatotic liver disease (MASLD). Journal of Endocrinological Investigation, 49(8), 2033-2043. https://doi.org/10.1007/s40618-026-02880-w

Vancouver

Milani I, Ciasca G, Chinucci M, Carnazzo V, Leonetti F, Basile U, et al. Fetuin-A: a potential molecular link between obesity, diabetes (type 2 and type 1) and metabolic steatotic liver disease (MASLD). Journal of Endocrinological Investigation. 2026;49(8):2033-2043. doi:10.1007/s40618-026-02880-w

BibTeX
@article{Milani2026,
  author = {Milani, Ilaria and Ciasca, Gabriele and Chinucci, Marianna and Carnazzo, Valeria and Leonetti, Frida and Basile, Umberto and Capoccia, Danila},
  title = {Fetuin-A: a potential molecular link between obesity, diabetes (type 2 and type 1) and metabolic steatotic liver disease (MASLD)},
  journal = {Journal of Endocrinological Investigation},
  year = {2026},
  volume = {49},
  number = {8},
  pages = {2033--2043},
  doi = {10.1007/s40618-026-02880-w}
}
Kostenlos starten →